A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as baricitinib in participants with moderately to severely active rheumatoid arthritis who have had an inadequate response to methotrexate therapy.
Epistemonikos ID: a5483322950b513889befc32bedb3a68901cef3d
First added on: Dec 18, 2021